51 related articles for article (PubMed ID: 7910544)
21. PTPN22 gene polymorphism in Behçet's disease.
Sahin N; Bicakcigil M; Atagunduz P; Direskeneli H; Saruhan-Direskeneli G
Tissue Antigens; 2007 Nov; 70(5):432-4. PubMed ID: 17868256
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphism detection by polymerase chain reaction-restriction fragment length polymorphism.
Ota M; Fukushima H; Kulski JK; Inoko H
Nat Protoc; 2007; 2(11):2857-64. PubMed ID: 18007620
[TBL] [Abstract][Full Text] [Related]
23. [Theoretical considerations on the herediatry component in widespread diseases].
Moraru I; Dumitrescu MS
Stud Cercet Med Interna; 1968; 9(3):187-98. PubMed ID: 5679696
[No Abstract] [Full Text] [Related]
24. Role of STAT3 Locus in autoimmune diseases.
Jabalameli MR
Genes Immun; 2011 Mar; 12(2):155; author reply 156. PubMed ID: 21209620
[No Abstract] [Full Text] [Related]
25. Clustering of autoimmune disease in families at high risk for multiple sclerosis?
Ramagopalan SV; Dyment DA; Herrera BM; Criscuoli M; Yee IM; Sadovnick AD; Ebers GC
Lancet Neurol; 2007 Mar; 6(3):206-7; author reply 207. PubMed ID: 17303524
[No Abstract] [Full Text] [Related]
26. Autoimmune disease and multiple sclerosis: methods, methods, methods.
Marrie RA
Lancet Neurol; 2007 Jul; 6(7):575-6. PubMed ID: 17582353
[No Abstract] [Full Text] [Related]
27. MS and autoimmune disorders.
Ebers GC
Neurogenetics; 2009 Feb; 10(1):1-3. PubMed ID: 18949493
[No Abstract] [Full Text] [Related]
28. Polymorphism in MS.
Steinman L; Oksenberg JR; Bernard CA
Neurology; 1992 Feb; 42(2):466-7. PubMed ID: 1346550
[No Abstract] [Full Text] [Related]
29. [Etiopathogenic considerations on multiple sclerosis with particular regard to the autoimmune hypothesis].
Giunta A; Palchetti R; Tortoli V
Rass Neurol Veg; 1965 Apr; 19(1):71-122. PubMed ID: 5325555
[No Abstract] [Full Text] [Related]
30. [Demyelinating diseases--with special reference to multiple sclerosis].
Araki S
Nihon Rinsho; 1971 Nov; 29(11):2469-75. PubMed ID: 5168796
[No Abstract] [Full Text] [Related]
31. UNUSUAL ONSETS OF MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO EARLY PARAESTHESIAS.
Saucier J
Can Med Assoc J; 1933 Jul; 29(1):44-6. PubMed ID: 20319164
[No Abstract] [Full Text] [Related]
32. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.
Sedimbi SK; Shastry A; Park Y; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():273-7. PubMed ID: 17130565
[TBL] [Abstract][Full Text] [Related]
33. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
[TBL] [Abstract][Full Text] [Related]
34. Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis.
Knudsen GP
J Neurol Sci; 2009 Nov; 286(1-2):43-6. PubMed ID: 19411081
[TBL] [Abstract][Full Text] [Related]
35. Alternative splicing in multiple sclerosis and other autoimmune diseases.
Evsyukova I; Somarelli JA; Gregory SG; Garcia-Blanco MA
RNA Biol; 2010; 7(4):462-73. PubMed ID: 20639696
[TBL] [Abstract][Full Text] [Related]
36. PCR and RFLP studies of inherited susceptibility to autoimmune disorders, with special reference to multiple sclerosis.
Fugger L
Dan Med Bull; 1994 Feb; 41(1):38-51. PubMed ID: 7910544
[No Abstract] [Full Text] [Related]
37. [Analysis of lymphocyte-T receptor in autoimmune diseases].
Lunardi C; Borgato L; De Sandre G
Recenti Prog Med; 1997 Feb; 88(2):82-4. PubMed ID: 9148373
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
